Esophageal Cancer Clinical Trials & Research

Researchers at Memorial Sloan Kettering are studying new approaches to esophageal cancer, and we come closer to finding exciting solutions every day. One of the most important goals we have is to develop better treatments for people with esophageal cancer who are not helped by standard treatments.

We lead clinical trials to make current treatments better and to enhance the quality of life for people with esophageal cancer. Eligible patients may get experimental treatments before they are widely available elsewhere.

Memorial Sloan Kettering’s clinical trials for esophageal cancer are listed below. There may be other trials that are right for your cancer. Consult with your physician, who can ask if a trial is right for you.

and/or
23 Clinical Trials found
The purpose of this study is to compare proton beam radiation therapy with intensity-modulated radiation therapy (IMRT) in patients with stage I-IVA esophageal cancer. Both approaches send radiation inside the body to a tumor without damaging much of the healthy tissue around it. However, proton beam radiation therapy uses protons while IMRT uses photons (high-energy x-rays).
To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.
To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.